RUNX2 is a cell-intrinsic brake on Th17 pathogenicity driven by neutrophil extracellular traps
Caleb Wong Han, Aaron H S Heng, Gabrielle Therese Belz, Anne Brüstle, Shaun R. McColl, Iain Comerford
This study shows RUNX2 suppresses Th17 pathogenicity in MS and EAE by inhibiting neutrophil extracellular trap-driven Th17 priming.
bioRxiv · Jun 26, 2025 · PreprintImmunology